Status:

COMPLETED

Clinical Study of STI Screening to Prevent Adverse Birth and New-born Outcomes (Philani Ndiphile)

Lead Sponsor:

Foundation for Professional Development (Pty) Ltd

Collaborating Sponsors:

University of Southern California

National Institutes of Health (NIH)

Conditions:

Sexually Transmitted Infection

HIV/AIDS

Eligibility:

FEMALE

Phase:

NA

Brief Summary

This study aims to evaluate different screening strategies to decrease the burden of Neisseria gonorrhoeae (NG), Chlamydia trachomatis (CT) and Trichomonas vaginalis (TV) among pregnant women, and red...

Detailed Description

Prevalence of STIs is high among pregnant women in South Africa and most infections remain untreated. Untreated infections impact on pregnancy and birth outcomes. Good diagnostic and point-of-care (PO...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for pregnant women:
  • Age≥18 years
  • Currently pregnant based on positive urine pregnancy test
  • Attending first ANC visit for current pregnancy
  • Gestational age \<20 weeks
  • Agreeing to nurse-collected specimens
  • Resident in Buffalo City Municipality (BCM)
  • Intent to deliver in one of the four midwife obstetric units (MOUs) in BCM
  • Gestational age will be confirmed via ultrasound
  • Exclusion Criteria:
  • Planning to relocate during pregnancy or deliver in an MOU outside of BCM
  • Unknown HIV status (e.g. refusal, invalid test result)
  • Currently participating in another ANC/HIV study
  • When the ultrasound confirms ≥20 weeks gestation at first ANC
  • Inclusion criteria for Neonates:
  • 1\) born to mothers that provided informed consent to participate in study, 2) provision of updated verbal consent by mother to collect and test specimens for STIs

Exclusion

    Key Trial Info

    Start Date :

    March 29 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    February 28 2025

    Estimated Enrollment :

    2247 Patients enrolled

    Trial Details

    Trial ID

    NCT04446611

    Start Date

    March 29 2021

    End Date

    February 28 2025

    Last Update

    July 30 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Buffalo City Metro

    East London, Eastern Cape, South Africa, 5217